...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Structure-activity relationships for the interaction of 5,10-dihydroindeno[1,2-b]indole derivatives with human and bovine carbonic anhydrase isoforms I, II, III, IV and VI.
【24h】

Structure-activity relationships for the interaction of 5,10-dihydroindeno[1,2-b]indole derivatives with human and bovine carbonic anhydrase isoforms I, II, III, IV and VI.

机译:5,10-二氢茚并[1,2-b]吲哚衍生物与人和牛的碳酸酐酶同工型I,II,III,IV和VI相互作用的结构活性关系。

获取原文
获取原文并翻译 | 示例
           

摘要

Several 5,10-dihydroindeno[1,2-b]indole derivatives incorporating methoxy, hydroxyl, and halogen (F, Cl, and Br) moieties on the indene fragment of the molecule were prepared and tested against five carbonic anhydrase (CA, EC 4.2.1.1) isoforms. The inhibitory potencies of these compounds against the human (h) isoforms hCA I, II, IV, VI and bovine (b) isoform bCA III were assessed. Most of them exhibited low micromolar inhibition of these enzymes. K(I) values of these compounds against hCA I and hCA II were in the range of 2.14-16.32 μM, and 0.34-2.52 μM, respectively. Isozyme hCA IV was inhibited with K(I)-s in the range of 0.435-5.726 μM, while hCA VI with K(I)-s of 1.92-12.84 μM bCA III was inhibited with K(I)-s in the range of 2.13-17.83 μM. The structurally related compounds, 1,2-dimethoxybenzene, catechol and indole were also tested in order to understand the structure activity relationship. In silico docking studies of some derivatives within the active site of hCA I and II were also carried out in order to rationalize the inhibitory properties of these compounds and understand their inhibition mechanism.
机译:制备了在分子的茚基片段上结合了甲氧基,羟基和卤素(F,Cl和Br)部分的5,10-二氢茚并[1,2-b]吲哚衍生物,并针对五种碳酸酐酶(CA,EC 4.2.1.1)同工型。评估了这些化合物对人(h)同工型hCA I,II,IV,VI和牛(b)同工型bCA III的抑制能力。它们中的大多数显示出对这些酶的低微摩尔抑制。这些化合物针对hCA I和hCA II的K(I)值分别在2.14-16.32μM和0.34-2.52μM的范围内。同工酶hCA IV在0.435-5.726μM范围内被K(I)-s抑制,而hCA VI在K(I)-s范围内被K(I)-s抑制为1.92-12.84μMbCA III。为2.13-17.83μM。为了理解结构活性关系,还测试了与结构相关的化合物1,2-二甲氧基苯,邻苯二酚和吲哚。在计算机对接研究中还对hCA I和II的活性位点内的某些衍生物进行了研究,以理顺这些化合物的抑制特性并了解其抑制机理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号